Afuco™ Anti-Human A33 ADCC Therapeutic Antibody (KRN330), ADCC Enhanced

Anti-A33 ADCC Enhanced Antibody (KRN330) is an ADCC enhanced antibody produced by our Afuco™ platform. KRN330 is a recombinant, fully-human monoclonal antibody directed against A33, a surface differentiation antigen on normal colonic epithelium, which is uniformly expressed in 95% of colorectal cancers.
Supplier Creative Biolabs
Product # AFC-002CL
Pricing Inquiry
Host Human
Target A33
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4°C or -20°C, avoid repeated freezing and thawing.
Feedback